Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
Plos One|April 21, 2021
Effects of realistic e-learning cases on students' learning motivation during COVID-19Ann-Kathrin Rahm, Maximilian Töllner, Max Ole Hubert, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 19, 2014
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancerLars Henning Schmidt, Dennis Görlich, Tilmann Spieker, et al.International Journal of Cancer|November 12, 2021
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cellsYi Liu, Sanmei Wang, Maria-Luisa Schubert, et al.Cancer Discovery|August 24, 2017
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T CellsThomas Shum, Bilal Omer, Haruko Tashiro, et al.Frontiers in Immunology|December 28, 2020
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T CellsMingya Yang, Lei Wang, Ming Ni, et al.Frontiers in Immunology|June 14, 2021
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell ImmunotherapyMingya Yang, Lei Wang, Ming Ni, et al.Cytotherapy|October 29, 2021
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cellsMing Ni, Lei Wang, Yuntian Ding, et al.Leukemia|July 6, 2023
The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemiaKatharina Weidenauer, Christina Schmidt, Christian Rohde, et al.British Journal of Haematology|March 5, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AMLSebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig, et al.Cancers|February 15, 2022
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic LeukemiaDaniela V Wenge, Klaus Wethmar, Corinna A Klar, et al.Pageof 8